Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Predicting survival in AIDS: refining the model

S J Hutchinson1, R P Brettle, S M Gore

  • 1MRC Biostatistics Initiative for AIDS and HIV in Scotland, Centre for HIV Research, Edinburgh, UK.

QJM : Monthly Journal of the Association of Physicians
|February 25, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel, multi-component contingency management intervention in the context of a syndemic of drug-related harms in Glasgow, Scotland: First year of the 'WAND' initiative.

Addictive behaviors reports·2025
Same author

Increased risk of non-fatal overdose associated with non-prescribed benzodiazepine use in Scotland, UK.

The International journal on drug policy·2023
Same author

Liver function tests in primary care provide a key opportunity to diagnose and engage patients with hepatitis C.

Epidemiology and infection·2022
Same author

Increasing drug-related mortality rates over the last decade in Scotland are not just due to an ageing cohort: A retrospective longitudinal cohort study.

The International journal on drug policy·2021
Same author

The Radical Cure of Aveolar Abscess.

The Dental register·2021
Same author

Complex differences in infection rates between ethnic groups in Scotland: a retrospective, national census-linked cohort study of 1.65 million cases.

Journal of public health (Oxford, England)·2021
Same journal

Trends in mortality of people on dialysis in England and Wales over the last 15 years.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Familial pulmonary fibrosis due to pathogenic TERT variant presenting with a UIP-PPFE phenotype.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Corkscrew Oesophagus Due to Distal Oesophageal Spasm.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Correction to: Integrated care management for patients following acute stroke: a systematic review.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Methodological concerns regarding blinding and long term efficacy of fire needle therapy for plaque psoriasis.

QJM : monthly journal of the Association of Physicians·2026
Same journal

Media framing of GLP-1/GIP therapies in Japan: Lessons for aging universal health coverage systems.

QJM : monthly journal of the Association of Physicians·2026
See all related articles

This study validates an AIDS staging system using AIDS-defining diseases (ADDs) and CD4 counts. Findings suggest regrading HIV dementia and highlight improved management of mild ADDs, impacting survival predictions.

Area of Science:

  • Immunology
  • Virology
  • Epidemiology

Background:

  • Assessing the prognostic value of existing AIDS staging systems is crucial for patient management.
  • The Edinburgh City Hospital Cohort provided a unique dataset, with 56% of patients being injecting drug users (IDUs).

Purpose of the Study:

  • To validate a previously published AIDS staging system.
  • To examine AIDS-defining diseases (ADDs) and CD4 counts as prognostic factors for survival.
  • To assess the impact of post-AIDS treatments on survival.

Main Methods:

  • Cox regression analysis was employed to model the risk of death.
  • The study analyzed data from 248 AIDS patients.
  • The Mocroft et al. system was used to grade disease severity.

Related Experiment Videos

Main Results:

  • HIV dementia was suggested for regrading to a very severe ADD (RR 3.9).
  • Zidovudine showed a reduced risk (RR 0.7) during AIDS follow-up for patients starting treatment post-diagnosis.
  • Improved management led to a 40% reduction in mild index diseases among IDUs and a three-fold risk reduction for mild ADDs.

Conclusions:

  • The study supports the significance of ADDs and lowest CD4 count in predicting survival for AIDS patients.
  • The findings suggest refinements to the existing staging system, particularly regarding HIV dementia.
  • Advances in managing mild ADDs have demonstrably improved patient outcomes.